Terms: = Prostate cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Diagnosis
27 results:
1. Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer.
Kang N; Xue H; Lin YY; Dong X; Classen A; Wu R; Jin Y; Lin D; Volik S; Ong C; Gleave M; Collins C; Wang Y
Cancer Gene Ther; 2023 Oct; 30(10):1382-1389. PubMed ID: 37452083
[TBL] [Abstract] [Full Text] [Related]
2. Ligand-Directed H
Cai X; Zhang J; Ye H; Cui K; Hao T; Yi L; Yang X
Chemistry; 2023 Aug; 29(44):e202301105. PubMed ID: 37243903
[TBL] [Abstract] [Full Text] [Related]
3. Human cancer Cell Radiation Response Investigated through Topological Analysis of 2D Cell Networks.
Tirinato L; Onesto V; Garcia-Calderon D; Pagliari F; Spadea MF; Seco J; Gentile F
Ann Biomed Eng; 2023 Aug; 51(8):1859-1871. PubMed ID: 37093401
[TBL] [Abstract] [Full Text] [Related]
4. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
Liu P; Wang W; Wang F; Fan J; Guo J; Wu T; Lu D; Zhou Q; Liu Z; Wang Y; Shang Z; Chan FL; Yang W; Li X; Zhao SC; Zheng Q; Wang F; Wu D
J Transl Med; 2023 Jan; 21(1):40. PubMed ID: 36681849
[TBL] [Abstract] [Full Text] [Related]
5. Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer.
Nunes-Xavier CE; Emaldi M; Guldvik IJ; Ramberg H; Taskén KA; Mælandsmo GM; Fodstad Ø; Llarena R; Pulido R; López JI
Pathol Res Pract; 2023 Jan; 241():154243. PubMed ID: 36481650
[TBL] [Abstract] [Full Text] [Related]
6. B7-H3 as a Therapeutic Target in Advanced prostate cancer.
Guo C; Figueiredo I; Gurel B; Neeb A; Seed G; Crespo M; Carreira S; Rekowski J; Buroni L; Welti J; Bogdan D; Gallagher L; Sharp A; Fenor de la Maza MD; Rescigno P; Westaby D; Chandran K; Riisnaes R; Ferreira A; Miranda S; Calì B; Alimonti A; Bressan S; Nguyen AHT; Shen MM; Hawley JE; Obradovic A; Drake CG; Bertan C; Baker C; Tunariu N; Yuan W; de Bono JS
Eur Urol; 2023 Mar; 83(3):224-238. PubMed ID: 36114082
[TBL] [Abstract] [Full Text] [Related]
7. Relevance of Circulating Nucleosomes, HMGB1 and sRAGE for prostate cancer diagnosis.
Garrido MM; Ribeiro RM; Krüger K; Pinheiro LC; Guimarães JT; Holdenrieder S
In Vivo; 2021; 35(4):2207-2212. PubMed ID: 34182498
[TBL] [Abstract] [Full Text] [Related]
8. Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients.
Ihle CL; Provera MD; Straign DM; Smith EE; Edgerton SM; Van Bokhoven A; Lucia MS; Owens P
J Immunother Cancer; 2019 Nov; 7(1):293. PubMed ID: 31703602
[TBL] [Abstract] [Full Text] [Related]
9. [A Case of Rectal cancer with Multiple Pulmonary and Liver Metastases Could Be Resected through Chemotherapy].
Nomura M; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Yamamoto H; Mizushima T; Doki Y; Mori M
Gan To Kagaku Ryoho; 2018 Jan; 45(1):169-171. PubMed ID: 29362344
[TBL] [Abstract] [Full Text] [Related]
10. SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway.
Qian B; Yao Y; Liu C; Zhang J; Chen H; Li H
Int J Oncol; 2017 May; 50(5):1601-1611. PubMed ID: 28339027
[TBL] [Abstract] [Full Text] [Related]
11. Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele.
Bentmar Holgersson M; Ruhayel Y; Karlsson M; Giwercman A; Bjartell A; Ohlsson C; Mellström D; Ljunggren Ö; Haghsheno MA; Damber JE; Lundberg Giwercman Y
Cancer Causes Control; 2017 Mar; 28(3):227-233. PubMed ID: 28176139
[TBL] [Abstract] [Full Text] [Related]
12. Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma.
Schäfer MH; Lingohr P; Sträßer A; Lehnen NC; Braun M; Perner S; Höller T; Kristiansen G; Kalff JC; Gütgemann I
Hum Pathol; 2015 Oct; 46(10):1488-95. PubMed ID: 26239623
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of phospho-histone H3 in prostate carcinoma.
Nowak M; Svensson MA; Carlsson J; Vogel W; Kebschull M; Wernert N; Kristiansen G; Andrén O; Braun M; Perner S
World J Urol; 2014 Jun; 32(3):703-7. PubMed ID: 23887713
[TBL] [Abstract] [Full Text] [Related]
14. Landscape of chromosome number changes in prostate cancer progression.
Braun M; Stomper J; Kirsten R; Adler D; Vogel W; Böhm D; Wernert N; Kristiansen G; Perner S
World J Urol; 2013 Dec; 31(6):1489-95. PubMed ID: 23512229
[TBL] [Abstract] [Full Text] [Related]
15. Methyltransferase inhibitor adenosine dialdehyde suppresses androgen receptor expression and prostate cancer growth.
Shiota M; Takeuchi A; Yokomizo A; Kashiwagi E; Tatsugami K; Naito S
J Urol; 2012 Jul; 188(1):300-6. PubMed ID: 22608750
[TBL] [Abstract] [Full Text] [Related]
16. The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes.
Magnani T; Valdagni R; Salvioni R; Villa S; Bellardita L; Donegani S; Nicolai N; Procopio G; Bedini N; Rancati T; Zaffaroni N
BJU Int; 2012 Oct; 110(7):998-1003. PubMed ID: 22404874
[TBL] [Abstract] [Full Text] [Related]
17. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.
Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F
J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475
[TBL] [Abstract] [Full Text] [Related]
18. [Expression of B7-H4 in prostate cancer and its clinical significance].
Qian Y; Yao HP; Shen L; Cheng LF; Zhang LH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):345-9. PubMed ID: 20731031
[TBL] [Abstract] [Full Text] [Related]
19. Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease.
Deligezer U; Yaman F; Darendeliler E; Dizdar Y; Holdenrieder S; Kovancilar M; Dalay N
Clin Chim Acta; 2010 Oct; 411(19-20):1452-6. PubMed ID: 20573596
[TBL] [Abstract] [Full Text] [Related]
20. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
[TBL] [Abstract] [Full Text] [Related]
[Next]
